VMA21 gene related symptoms and diseases

All the information presented here about the VMA21 gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: ORPHANET,OMIM,NCBIGENE,HGNC, Mendelian Rare Disease Search Engine.

Top 5 symptoms and clinical features associated to VMA21 gene

Symptoms // Phenotype % Cases
Global developmental delay Very Common - Between 80% and 100% cases
Muscle weakness Very Common - Between 80% and 100% cases
Myopathy Very Common - Between 80% and 100% cases
Elevated serum creatine phosphokinase Very Common - Between 80% and 100% cases
Neonatal hypotonia Very Common - Between 80% and 100% cases

Other less frequent symptoms and clinical features

Patients with VMA21 gene alterations may also develop some of the following symptoms and phenotypes:
  • Commonly - More than 50% cases

  • Hypertrophic cardiomyopathy
  • Generalized muscle weakness
  • Autophagic vacuoles
  • Generalized hypotonia
  • Not very common - Between 30% and 50% cases

  • Bundle branch block
  • Ventricular hypertrophy
  • Left ventricular hypertrophy
  • Progressive muscle weakness

And 28 more phenotypes, you can get all of them using our tools for rare diseases.

Rare diseases associated to VMA21 gene

Here you will find a list of rare diseases related to the VMA21. You can also use our tool to get a more accurate diagnosis based on your current symptoms.


X-LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY

Alternate names

X-LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY Is also known as xmea, vacuolar myopathy

Description

X-linked myopathy with excessive autophagy is a childhood-onset X-linked myopathy characterised by slow progression of muscle weakness and unique histopathological findings.

Most common symptoms of X-LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY

  • Global developmental delay
  • Generalized hypotonia
  • Muscle weakness
  • Cardiomyopathy
  • Myopathy


More info about X-LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY

SOURCES: OMIM ORPHANET

MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX

Alternate names

MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX Is also known as xmea

Description

X-linked myopathy with excessive autophagy (XMEA) is an X-linked recessive skeletal muscle disorder characterized by childhood onset of progressive muscle weakness and atrophy primarily affecting the proximal muscles. While onset is usually in childhood, it can range from infancy to adulthood. Many patients lose ambulation and become wheelchair-bound. Other organ systems, including the heart, are clinically unaffected. Muscle biopsy shows intracytoplasmic autophagic vacuoles with sarcolemmal features and a multilayered basal membrane (summary by Ramachandran et al., 2013; Kurashige et al., 2013, and Ruggieri et al., 2015).Danon disease (OMIM ), caused by mutation in the LAMP2 gene (OMIM ) on chromosome Xq24, is a distinct disorder with similar pathologic features.

Most common symptoms of MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX

  • Global developmental delay
  • Generalized hypotonia
  • Scoliosis
  • Muscle weakness
  • Flexion contracture


More info about MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX

SOURCES: OMIM


Potential gene panels for VMA21 gene

Myopathy, with excessive autophagy, X-linked (sequence analysis of VMA21 gene) Panel

Portugal.

By CGC Genetics

This panel specifically test the VMA21 gene.

More info about this panel
Portugal.

Lysosomal and peroxisomal diseases (NGS panel of 109 genes) Panel

Portugal.

By CGC Genetics Lysosomal and peroxisomal diseases (NGS panel of 109 genes) that also includes the following genes: SC5D SCP2 SGSH SHOX SLC17A5 SMPD1 TCIRG1 ACOX1 ACP2 MCOLN1

More info about this panel
Portugal.

Lysosomal and peroxisomal diseases (NGS panel of 109 genes) Panel

Portugal.

By CGC Genetics Lysosomal and peroxisomal diseases (NGS panel of 109 genes) that also includes the following genes: SC5D SCP2 SGSH SHOX SLC17A5 SMPD1 TCIRG1 ACOX1 ACP2 MCOLN1

More info about this panel
Portugal.

Congenital and Distal Myopathies Panel Panel

Germany.

By CeGaT GmbH Congenital and Distal Myopathies Panel that also includes the following genes: RYR1 BIN1 STIM1 SUCLA2 TWNK TIA1 TK2 TNNT1 TPM2 TPM3

More info about this panel
Germany.

Invitae Comprehensive Neuromuscular Disorders Panel Panel

United States.

By Invitae Invitae Comprehensive Neuromuscular Disorders Panel that also includes the following genes: RYR1 BIN1 SCN4A SGCA SGCB SGCD SGCG SMN1 SMN2 SQSTM1

More info about this panel
United States.

Invitae Autophagic Vacuolar Myopathy Panel Panel

United States.

By Invitae Invitae Autophagic Vacuolar Myopathy Panel that also includes the following genes: VMA21 DES LAMP2

More info about this panel
United States.

VMA21 Panel

United States.

By Fulgent Genetics Fulgent Genetics

This panel specifically test the VMA21 gene.

More info about this panel
United States.

X-chromosome High Resolution microarray analysis Panel

United States.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center X-chromosome High Resolution microarray analysis that also includes the following genes: RP2 RPGR RPL10 RPS6KA3 RS1 SAT1 SH2D1A SHOX SLC16A2 SLC35A2

More info about this panel
United States.

LGMD and Congenital Muscular Dystrophy Panel Panel

Finland.

By Blueprint Genetics LGMD and Congenital Muscular Dystrophy Panel that also includes the following genes: SGCA SGCB SGCD SGCG TCAP MYOT TTN CAPN3 DNAJB6 CAV3

More info about this panel
Finland.

Comprehensive Muscular Dystrophy / Myopathy Panel Panel

Finland.

By Blueprint Genetics Comprehensive Muscular Dystrophy / Myopathy Panel that also includes the following genes: SGCA SGCB SGCD SGCG TCAP TNNT1 TPM2 TPM3 MYOT TTN

More info about this panel
Finland.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like ZNF711 DYM QDPR JMJD1C PIGW GPAA1 CHD1